The transcription factors that act in hepatocyte-specific gene expression include proteins that are present mainly in liver cells (HNF-1/LFB1, C/EBP, HNF-3, HNF-4) (HNF, hepatocyte nuclear factor; C/EBP, rat enhancer binding protein) and proteins that are widely distributed (AP-1, NF-1, NF-Y/ACF). We show here that the genes encoding each of these liver-enriched factors exhibit different patterns of transcriptional control in different tissues. In addition, there were several instances in which transcription was detected (e.g., for HNF-1) when no mRNA or specific DNA binding protein was found, suggesting the importance of posttranscriptional control in some instances for these factors. These experiments identify C/EBP, HNF-3, and HNF-4, and perhaps also HNF-1, as targets for the study of cascades of transcriptionally controlled transcription factors in differentiated cells.
A cascade of sequential transcriptional controls has been shown to be the basis for early Drosophila development (1, 2) . This conclusion was reached by identifying genes that disable embryos at successively earlier stages, cloning and sequencing those genes, and comparing the amino acid sequence motifs to those of known transcription factors. Consecutive waves of expression of genes encoding transcription factors were identified by this approach. In the belief that mammalian determination is also likely to involve cascades of transcription factors, many laboratories have been identifying transcription factors that function in hepatocyte-specific gene expression (reviewed in ref. 3) . Among such factors, we hoped to find some that were transcribed in hepatocytes but not in other cell types. Analysis of the regulation of such transcriptionally controlled transcription factors might then lead to the identification of genes active earlier in the potential cascade.
The regulatory regions of all of the genes so far examined that are expressed only or mainly in the mouse liver have multiple DNA binding sites, each of which is required in transient transfection or in vitro transcription experiments to allow full cell-specific expression of a reporter gene (4) (5) (6) (7) (8) (9) (10) (11) . The proteins identified as binding to several functionally important sites include four factors that, based on DNA binding assays, are present in liver nuclear extracts but are not found in many other cell types. These are as follows: HNF-1/LFB1, a homeo-domain protein (HNF, hepatocyte nuclear factor) (12, 13) ; C/EBP (a rat DNA binding protein), the original leucine zipper protein (14) ; HNF-3a, a protein with sequence similarity to the Drosophila gene forkhead (15, 25, 26) ; HNF-4, a distinct member of the steroid-thyroid hormone receptor superfamily (16) . In addition, there are binding sites for widely distributed proteins such as AP-1 (17), NF-1 (18) , and NF-Y/ACF (11) . Recently, a liverenriched transcriptional activator, D/EBP, has been described (19) that binds mutually exclusively to the same site as C/EBP in the albumin promoter but its tissue specificity is determined posttranscriptionally.
The availability of cDNA clones of all four of the factors that are restricted in their tissue distribution makes it possible to determine the transcription rate of the genes encoding each of these factors, the mRNA levels, and the corresponding DNA binding activities in a variety of tissues (20) . Here we show that a major part of the basis for the limited tissue distribution of these factors is the transcriptional regulation of their genes. In addition, there was clear evidence that the HNF-1/LFB1 gene and possibly the HNF-3a gene were transcribed in the spleen where no corresponding mRNA or DNA binding proteins existed, thus suggesting that posttranscriptional regulation also occurs in some instances.
MATERIALS AND METHODS
Northern Blot Analysis. Northern blot analysis was carried out on poly(A)-containing RNA from various rat tissues by using agarose formaldehyde gels. Hybond-N filter (Amersham) for RNA attachment and hybridization was used as described (15, 16, 25, 26) with SDS/2 mM EDTA/heat denaturated salmon sperm DNA (100 ,ug/ml). Exposure times at -70°C were as follows: HNF-1/LFB1, 36 hr; C/EBP, 24 hr; HNF-3, 72 hr; HNF-4, 24 hr; glyceraldehyde-3-phosphate dehydrogenase, 8 hr.
Preparation of Nuclear Extracts and Gel-Retardation Assays. Crude rat liver nuclear extracts were prepared as described (4) . Gel retardation assays were carried out in 15 kdl as described (4 (19) .
Only the upper strand is shown. Lowercase nucleotides indicate residues not present in the authentic sequence but used as cloning sites.
Nuclear Run-On Transcription Assays. Isolated nuclei from various rat tissues were used immediately under conditions of RNA chain elongation in the presence of [a-32P]UTP as described (20) and the labeled RNA was hybridized to immobilized DNA as described (20) . The following probes were used: tRNAMet; control, pBluescript or pGEM1; studied genes that are expressed mainly in the liver: transthyretin, a1-antitrypsin, and albumin (4-11 liver-enriched factors, proteins that bind an AP-1 binding site are distributed about equally in all tissues (Fig. 2B) .
Individual proteins capable of producing the liver-enriched gel-shift reactions shown in Fig. 2 have been purified and the cDNAs encoding each pure protein identified (12) (13) (14) (15) (16) . With these cDNA clones, Northern blots confirm the differential distribution of the four proteins (Fig. 3) . The HNF-1 cDNA detects two major mRNA bands in both liver and kidney, but not in spleen, brain, and lung. The labeled C/EBP cDNA detects an mRNA in liver and lung but not in kidney, spleen, or brain RNA. HNF-3 and 4 mRNAs were found in lung and kidney, respectively, as well as in liver. These assays using total organ RNAs obviously miss the contribution of small numbers of cells in any organ; for example, we have found C/EBP in the hippocampus but the mRNA is not detectable in whole brain RNA (21) . The Northern blot analysis never-B theless allows a determination of expression of the largest amounts of each of the four specific mRNAs for the liverenriched group of factors and points to the differential presence or absence of mRNAs in organs other than the liver.
To determine whether the observed differential distribution of the proteins and mRNAs for HNF-1, -3, -4, and C/EBP was based on differential transcription of the genes encoding these factors, transcriptional "run-on" assays were carried out with nuclei from various rat tissues (20) . Nuclei were isolated and labeled nascent RNA was extracted after chain elongation in the presence of [a-32P]UTP. The newly transcribed RNA was hybridized to a variety of DNA samples immobilized on filters. After extensive high-stringency washes and RNase A and T1 digestion, the filters were subjected to autoradiography. Densitometric scanning and normalization to a standard (tRNAMet) allows a comparison oftranscription rates ofvarious genes in different tissues. The autoradiogram of a typical experiment is shown in Fig. 4A , and the average values from normalized densitometric tracings for at least four experiments are shown in Fig. 4B . The results show that C/EBP is transcribed in the liver nuclei at the highest rate of any of the hepatocyte-enriched factors. Transcription of C/EBP occurred at significant but lower levels in the lung and was detectable at low levels in the spleen and kidney, as reported previously (22), although no mRNA was observed in these tissues. No transcriptional signal for C/EBP was observed in the brain, although as mentioned we have found mRNA reactive with labeled C/EBP cDNA by in situ hybridization in selected brain locations (21) . This indicates that the conventional run-on assay, like a Northern blot assay, may not be sensitive enough to detect a signal in a situation in which say 5% or fewer of the cells are actively transcribing a given gene.
The transcriptional signal for HNF-3a was distinct but much lower than C/EBP in liver nuclei. A transcriptional signal for HNF-3a was also found in the lung, where the mRNA is definitely present, and in one spleen sample (shown in Fig. 4A ) but not in other spleen samples or in the other tissues tested (Fig. 4B) .
HNF-4 was transcribed in kidney at a higher rate than in liver but was not transcribed at detectable rates in brain, spleen, or lung nuclei, thus explaining the distribution of HNF-4 mRNA and protein that binds the HNF-4 oligonucleotide site.
Transcription of the HNF-1/LFB1 gene showed a distinct but weak signal in liver nuclei and an even stronger signal was seen consistently with nuclear RNA from kidney, where the mRNA is abundant, and in the spleen, where no HNF-1/ LFB1 mRNA was found. In addition, a weak HNF-1/LFB1 transcriptional signal was also seen in lung and brain (Fig.  4B) , which also lack this mRNA and protein.
DISCUSSION
It was established some time ago that regulation at the transcriptional level accounts for hepatocyte-specific expression of a wide variety of genes (23, 24) . The simplest explanation governing such regulation would have been the existence of one or a few hepatocyte-specific transcription factors that did not exist in other cell types. This explanation in its simplest form does not seem correct; all genes expressed only or mainly in hepatocytes whose regulatory regions have been dissected have many different DNA elements that can bind different transcription factors and no single factor appears to be universally required for hepatocyte-specific function. Moreover, some of the factors are present in many, perhaps all, tissues and no factor (so far discovered) is strictly limited to the liver. Finally, it must be remembered that the precise mechanistic role in transcription is not known for any of the factors so far. It nevertheless represents considerable progress to know that after dissecting the regulatory regions of only a half dozen genes (genes that are themselves unrelated) the same factors (both restricted and widely distributed) have been encountered as likely participants in regulating hepatocyte expression. Therefore it seems valid to conclude that liver-specific transcription does require a battery of transcription factors that exhibit a limited tissue distribution, among which are HNF-1, C/EBP, HNF-3, and HNF-4. It is a logical extension to assume that the regulation of the genes encoding these factors with limited tissue distribution is a key element in liver determination and differentiation. To ascend the presumed cascade of regulation we need to know which of the genes for cell-restricted factors are themselves under transcriptional control in hepatocytes. That question is addressed by the work in this paper.
The major level of control for C/EBP, HNF-3, and HNF-4 is transcriptional. C/EBP is transcribed most actively in hepatocytes (among tissues tested) and its mRNA is most prominent in liver compared to kidney, spleen, and brain. A lower transcription rate of C/EBP in lung is matched by a definite presence of mRNA in that organ. Very low rates of apparent C/EBP transcription in organs in which no C/EBP mRNA was found could be due to any of several causes.
Since the C/EBP transcription rate is so high in liver, whereas its mRNA concentration is quite low (22) , its mRNA may be quite unstable. In organs in which C/EBP is minimally active transcriptionally, its mRNA may simply not accumulate to detectable levels. Alternatively, the explanation may be technical. While the RNase treatment of hybrids in the run-on assay is quite stringent, if other genes exist with very close nucleic acid sequence similarity, this low level of transcription (1-5%; see Fig. 4A for C/EBP) might represent cross-hybridization. The HNF-4 gene gave transcriptional signals in only liver and kidney, and these were the tissues containing HNF-1 mRNA. Likewise, HNF-3 mRNA was present in liver and lung, the only tissues tested that gave a consistent transcriptional signal for this gene. Under strict conditions, the HNF-3 gene probe that was used in these experiments will not cross-hybridize with HNF-3P or -y, two newly described members of this family (15, 25, 26 (19) , it is also clear that either cell-specific translation or possibly activation of already existing activator proteins can also exist. Furthermore, there are possible cell-specific differences in the metabolism of the mRNA. For example, C/EBP is transcribed at a considerably higher rate than is HNF-3 or HNF-4 but there is only -4 times as much C/EBP mRNA as HNF-4 mRNA in the liver. Thus, while these genes may be primarily controlled by transcription they may also undergo some posttranscriptional regulation.
What can we make of the tissue distribution of the group of factors that appear to play a role in hepatocyte-specific transcription? First, it is clear that the nonhepatocyte adult tissues in which these factors are found are not identical: for example, HNF-4 was found in the kidney but not in the lung, while the opposite appears to be true for HNF-3. To be certain of cellular distributions within organs, experiments with specific antibodies to these factors are in order, but it already seems very likely that these factors are not distributed according to some already understood cellular lineages: for example, we have described C/EBP in cells of endodermal and ectodermal lineage (21) and HNF-4 appears in hepatocytes and in the kidney, which are derived from endodermal and mesodermal cells, respectively. Perhaps the only generalization at present that aids in understanding cell-specific expression is that only the liver contains high concentrations of HNF-1/LFB1, C/EBP, HNF-3, and HNF-4. Thus, perhaps the simultaneous expression of all these factors is required in either establishing or maintaining transcription of the appropriate hepatocyte-specific mRNAs.
